{
 "@context" : "http://schema.org",
  "id" : "http://bio2rdf.org/drugbank:DB00093",
  "type" : "Drug",
  "alternateName" : "Felypressinum",
  "description" : "A synthetic nonapeptide comprising cysteinyl, phenylalanyl, phenylalanyl, glutaminyl, asparaginyl, cysteinyl, prolyl, lysyl, and glycinamide residues in sequence, with a disulfide bridge joining the two cysteine residues. Its antidiuretic effects are less than those of vasopressin. It is used as a vasoconstrictor in local anaesthetic injections for dental use, and is an ingredient of preparations that have been used for treatment of pain and inflammation of the mouth. [ChEBI]",
  "legalStatus" : "approved",
  "manufacturer" : "Novartis pharmaceuticals corp",
  "mechanismOfAction" : "Felypressin binds to the vasopressin receptor V1a. This causes contraction of the smooth muscle in the vascular bed, especially capillaries, small arterioles and venules.",
  "name" : "Felypressin",
  "schema:sameAs" : "https://www.drugbank.ca/drugs/DB00093",
  "schema:url" : "https://www.drugbank.ca/drugs/DB00093"
}